Autoimmunity

A core set of risk factors in individuals at risk of rheumatoid arthritis: a systematic literature review informing the EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis
Kulveer Mankia, Heidi Siddle, Andrea Di Matteo, Deshiré Alpízar-Rodríguez, Joel Kerry, Andreas Kerschbaumer, Daniel Aletaha, Paul Emery

RMD Open Sep 2021, 7 (3) e001768; DOI: 10.1136/rmdopen-2021-001768
New risk model is able to identify patients with a low risk of progression in systemic sclerosis
Nina Marijn van Leeuwen, Marc Maurits, Sophie Liem, Jacopo Ciaffi, Nina Ajmone Marsan, Maarten Ninaber, Cornelia Allaart, Henrike Gillet van Dongen, Robbert Goekoop, Tom Huizinga, Rachel Knevel, Jeska De Vries-Bouwstra

RMD Open May 2021, 7 (2) e001524; DOI: 10.1136/rmdopen-2020-001524
Current view on the pathogenic role of anti-citrullinated protein antibodies in rheumatoid arthritis
Anca Catrina, Akilan Krishnamurthy, Bence Rethi

RMD Open Mar 2021, 7 (1) e001228; DOI: 10.1136/rmdopen-2020-001228
Association between T follicular helper cells and T peripheral helper cells with B-cell biomarkers and disease activity in primary Sjögren syndrome
Anastasia Dupré, Juliette Pascaud, Elodie Rivière, Audrey Paoletti, Bineta Ly, Michael Mingueneau, Xavier Mariette, Gaetane Nocturne

RMD Open Mar 2021, 7 (1) e001442; DOI: 10.1136/rmdopen-2020-001442
Biological agents for rheumatic diseases in the outbreak of COVID-19: friend or foe?
Cristiana Sieiro Santos, Xenia Cásas Férnandez, Clara Moriano Morales, Elvira Díez Álvarez, Carolina Álvarez Castro, Alejandra López Robles, Trinidad Pérez Sandoval

RMD Open Jan 2021, 7 (1) e001439; DOI: 10.1136/rmdopen-2020-001439
Strategies for the assessment of competences during rheumatology training across Europe: results of a qualitative study
Aurélie Najm, Alessia Alunno, Francisca Sivera, Sofia Ramiro, Catherine Haines

RMD Open Jul 2020, 6 (2) e001183; DOI: 10.1136/rmdopen-2020-001183
Autoantigen TRIM21/Ro52 is expressed on the surface of antigen-presenting cells and its enhanced expression in Sjögren’s syndrome is associated with B cell hyperactivity and type I interferon activity
Maarten R Hillen, Katia Urso, Emma Koppe, Ana Pinheiro Lopes, Sofie L M Blokland, Aridaman Pandit, Tom Slocombe, André van Maurik, Joel A G van Roon, Timothy R D J Radstake

RMD Open Jun 2020, 6 (2) e001184; DOI: 10.1136/rmdopen-2020-001184
Distinct features distinguishing IgG4-related disease from multicentric Castleman's disease
Takanori Sasaki, Mitsuhiro Akiyama, Yuko Kaneko, Takehiko Mori, Hidekata Yasuoka, Katsuya Suzuki, Kunihiro Yamaoka, Shinichiro Okamoto, Tsutomu Takeuchi

RMD Open Jul 2017, 3 (1) e000432; DOI: 10.1136/rmdopen-2017-000432
Automated evaluation of ANA under real-life conditions
Clemens Dario Loock, Karl Egerer, Eugen Feist, Gerd-Rüdiger Burmester

RMD Open Apr 2017, 3 (1) e000409; DOI: 10.1136/rmdopen-2016-000409
Dermatomyositis flare on imiquimod therapy highlights a crucial role of aberrant TLR7 signalling
Alain Meyer, Ghada Alsaleh, Claude Heuschling, Jacques-Eric Gottenberg, Philippe Georgel, Benard Geny, Seiamak Bahram, Jean Sibilia

RMD Open Oct 2016, 2 (2) e000294; DOI: 10.1136/rmdopen-2016-000294

Main menu

Autoimmunity

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Autoimmunity

Pages